Donor Screening/Laboratory Testing

In addition to the intense donor screening process and the 12 laboratory tests required by regulatory agencies on each unit collected, the Blood Center has many other programs which are vital for providing the safest possible product to the transfusion recipients
Donor Screening Tests
ABO/Rh used to determine the blood type of the donor.
CHOL Cholesterol
RPR qualitative screening test for the detection of syphilis.
Antibody Screen used in the detection of unexpected antibodies to red cells in order to prepare or select donor units for transfusion.
HIV-1/2(Human Immunodeficiency Virus Types 1 and 2) used to detect antibodies to HIV-1 and/or HIV-2 and to identify potentially infectious units of donated blood and plasma.
HTLV-I/II (Human T-Lymphotropic Virus Types I & II) used as a screen for donated blood to prevent transmission of HTLV-I and HTLV-II to recipients of blood components.
HbsAg (Hepatitis B Surface Antigen) used as a qualitative and/or semi-quantitative test of total antibody to Hepatitis B Surface Antigen as an aid in the diagnosis of Acute Hepatitis B.
HIV-1 p24 Antigen used for screening blood donors at unknown risk for HIV-1 infection.
HBC (Hepatitis B core Antibody) used for the detection of total antibody to Hepatitis B virus core antigen, screening of blood and blood products intended for transfusion and as an aid in the diagnosis of ongoing or previous Hepatitis B virus infection.
HCV (Hepatitis C Virus) used to detect antibody to Hepatitis C Virus.
CMV (Cytomegalovirus) Total Antibody used as a screen for the presence of antibody to CMV in blood or plasma donors.
NAT-HCV & NAT HIV - Nucleic Acid Testing (NAT) utilizes highly specific probes to detect the DNA (deoxyribonucleic acid) and/or RNA (ribonucleic acid) of the Hepatitis C virus and the Human Immunodeficiency Virus
West Nile Virus
Confirmatory Tests performed in-house:
HIV-1 p24 Antigen Neutralization Test
HbsAg Confirmatory Test (Neutralization)